NCT06536933

Study of Metabolic Dysfunction-Associated Steatotic Liver Disease Among Sohag University Employees

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Sohag University · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: —

Summary

* Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for steatotic liver disease associated with metabolic syndrome. MASLD is a common cause of chronic liver disease and is the leading cause of liver-related morbidity and mortality. * The high prevalence of this disease has been fueled by the rapid rise in levels of sedentary behavior, low levels of physical activity, excess calorie intake relative to expenditure in nutritionally imbalanced and unhealthy diets. In parallel, the prevalence of poor metabolic health in adults from many countries is high, even in normal weight individuals. * MASLD has been estimated to affect 30% of the adult population worldwide, with its prevalence increasing from 22% to 37% from 1991 to 2019 . The increasing prevalence of MASLD parallels the increasing prevalence of obesity and obesity-related diseases.

Conditions

• Metabolic Dysfunction-Associated Steatotic Liver Disease

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Abdominal Ultrasound	Diagnostic non invasive Abdomibal Ultrasound will be done to quantify hepatic steatosis

Timeline

• Start date: 2024-09-01
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2024-08-05
• Last updated: 2024-08-05

Locations

1 site across 1 country: Egypt